Table 1.
Summary of number of samples analyzed
| Cancer type | Subjects | 10% fraction |
20% fraction |
40% fraction |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Samples | Replicates | Spectra | Samples | Replicates | Spectra | Samples | Replicates | Spectra | ||
| Breast | 39/39 | 38/35 | 3 | 219 | 36/37 | 3 | 219 | Not tested | ||
| Ovarian | 47/50/98 | 47/50/98 | 1 | 195 | 46/50/95 | 1 | 191 | 47/50/97 | 1 | 194 |
| Prostate | 10/10 | 10/10 | 6–8 | 125 | 10/10 | 5–7 | 127 | 10/10 | 6 | 120 |
Slashes indicate normal/cancer cases for prostate and breast cancer samples and normal/borderline/cancer cases for ovarian cancer samples. See Section 1.